Several biological mechanisms contribute to the onset and exacerbation of inflammation and oxidative stress, including mitochondrial activity, xanthine oxidase, and Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase, which exacerbate VC in patients with CKD [19]. This evidence concerns the gene FMO5 and chronic kidney disease.